top headlines
Theranica’s Nerivio wearable migraine therapy is now covered by health [...]
Messenger RNA (mRNA) technology could offer a new approach to [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
A Phase 1/1b clinical trial has begun in Australia to [...]
ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]
Quest Diagnostics has integrated its Haystack MRD test and comprehensive [...]
Seegene has launched a global clinical study involving one million [...]
Fonseca Biosciences has launched XTORO (finafloxacin otic suspension) 0.3% in [...]
Autolomous and Cellular Origins have integrated their manufacturing platforms to [...]
